While comparisons are frequently made between PMT and EMT, the naming of the mesenchymal glioblastoma subtype was based largely on the two markers CD44 and MERTK, with the latter being an unconventional mesenchymal marker [2]. The gene discussed is MERTK; the disease is glioblastoma.